Oral submucous fibrosis (OSF) is a serious disease that impairs mouth functionality, often leading to restricted opening and a high risk of malignant transformation. New research has uncovered a ...

Allow the Sale, Sharing or use of My Personal information for Targeted Advertising If you switch this toggle to “no,” we will not sell or share your personal information with third parties for ...

patented oral solution of desmopressin under development for the treatment of central diabetes insipidus. The Company expects the application to be assigned a 10-month FDA review, allowing for ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. The candidate fell short in a phase 2 psoriasis trial, prompting the French drugmaker to pull back from plans to ...

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical data. The latest results show a high starting dose, fast titration model ...

The Supreme Court has notably also heard oral arguments this past term in other religious liberty and gender-related suits. The high court heard oral arguments earlier this month in a suit brought ...

SHANGHAI, April 23 (Reuters) - Mercedes-Benz (MBGn.DE), opens new tab CEO Ola Källenius said on Wednesday the German automaker was urging the European Union to find an "equitable solution" to ...

"There’s no basis for denying opt-outs for religious reasons," Baxter said during oral arguments. "Parents, not school boards, should have the final say on such religious matters." Justice ...

Recalled products include: • 13,104 cases of Lubricant Eye Drops Solution; national drug code NDC 50268-126-15 • 32,876 cases of Carboxymethylcellulose Sodium Ophthalmic Solution; NDC 50268 ...

Having said that, Boston appeared to be working on a new solution for that positional logjam on May 16. MLB.com Red Sox beat writer Ian Browne shared video of breakout prospect Kristian Campbell ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment Wegovy, Novo Nordisk has asked the FDA to approve it. A company ...